Aripiprazole for sexually inappropriate vocalizations in frontotemporal dementia

Journal of Clinical Psychopharmacology

Volumn 33, Issue 1, 2013, Pages 145-146

  Reeves, Roy R ^a   Perry, Candace L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE;

ADULT; BEHAVIOR DISORDER; BRAIN ATROPHY; CASE REPORT; COGNITIVE DEFECT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; HISTOPATHOLOGY; HUMAN; LETTER; LOW DRUG DOSE; MALE; MEMORY DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY DISORDER; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL VOCALIZATION; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME; VOCALIZATION;

EID: 85027956017     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/01.jcp.0000426190.64916.3b     Document Type: Letter

References (10)

1. Mendez MF, Shapira JS. The spectrum of recurrent thoughts and behaviors in frontotemporal dementia. CNS Spectr. 2008;13:202-208.
2. Johnson JK, Diehl J, Mendez MF, et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol. 2005;62:925-930.
3. Hodges JR, Davies RR, Xuereb JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56:399-406.
4. Boxer AL, Boeve BF. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Alzheimer Dis Assoc Disord. 2007;21:S79-S87.
5. Croxtall JD. Aripiprazole: a review of its use in the management of schizophrenia in adults. CNS Drugs. 2012;26(2):155-183.
6. Marcus RN, Owen R, Kamen L, et al. A placebo-controlled, fixed dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(11):1110-1119.
7. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorders. Pediatrics. 2009;124(6): 1533-1540.
8. McPheeters ML, Warren Z, Sathe N, et al. A systematic review of medical disorders for children with autistic spectrum disorders. Pediatrics. 2011;127:e1312-e1321.
9. Fellgiebel A, Muller MJ, Hiemke C, et al. Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed glucose metabolism. World J Biol Psychiatry. 2007;8:123-126.
10. Ballard C, Corbett A. Management of neuropsychiatric symptoms in people with dementia. CNS Drugs. 2012;24(9):729-739.